CN102579673B - Application of fresh rehmannia root aqueous extract in preparation of estrogen medicines - Google Patents
Application of fresh rehmannia root aqueous extract in preparation of estrogen medicines Download PDFInfo
- Publication number
- CN102579673B CN102579673B CN201210066495.9A CN201210066495A CN102579673B CN 102579673 B CN102579673 B CN 102579673B CN 201210066495 A CN201210066495 A CN 201210066495A CN 102579673 B CN102579673 B CN 102579673B
- Authority
- CN
- China
- Prior art keywords
- estrogen
- water extract
- fresh rehmannia
- rehmannia glutinosa
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及鲜地黄水提物在制备雌激素类药物中的应用,可有效解决制备由于体内雌性激素分泌不足而引起的相关疾病的药物,从而有效解决由于体内雌性激素分泌不足而引起的相关疾病的治疗用药问题,该鲜地黄水提物是,将鲜地黄每次用其10倍重量的水煎煮2次,每次2h,合并2次水煎液,减压浓缩干燥得到鲜地黄水提物,该鲜地黄水提物可有效用于制备治疗由于体内雌性激素分泌不足而引起的相关疾病的药物,实现鲜地黄水提物在制备治疗由于体内雌性激素分泌不足而引起的相关疾病药物中的应用,本发明水提物制备方法简单,稳定可靠,方便,成本低,有效用于制备雌激素类药物,开辟了鲜地黄药用新用途。
The invention relates to the application of fresh rehmannia glutinosa water extract in the preparation of estrogen drugs, which can effectively solve the preparation of related diseases caused by insufficient secretion of estrogen in the body, thereby effectively solving the related diseases caused by insufficient secretion of estrogen in the body For the treatment of medication problems, the fresh rehmannia water extract is to decoct the fresh rehmannia glutinosa twice with water 10 times its weight each time, for 2 hours each time, combine the decoctions twice, concentrate and dry under reduced pressure to obtain the fresh rehmannia water extract The water extract of fresh rehmannia glutinosa can be effectively used in the preparation of medicines for treating related diseases caused by insufficient secretion of estrogen in the body, and realize that the water extract of fresh rehmannia glutinosa can be used in the preparation of medicines for related diseases caused by insufficient secretion of estrogen in the body. application, the preparation method of the water extract of the present invention is simple, stable, reliable, convenient, low in cost, effectively used for preparing estrogen drugs, and opens up a new medicinal use of fresh rehmannia glutinosa.
Description
技术领域 technical field
本发明涉及医药,特别是一种鲜地黄水提物在制备雌激素类药物中的应用,鲜地黄水提物具有雌激素样作用,有效用于由于体内雌性激素分泌不足而引起的相关疾病(如妇女更年期综合症等)的治疗用药问题。The invention relates to medicine, in particular to the application of fresh rehmannia glutinosa water extract in the preparation of estrogen drugs. The fresh rehmannia glutinosa water extract has estrogen-like effects and is effectively used for related diseases caused by insufficient secretion of estrogen in the body ( Such as the treatment of women's menopause syndrome, etc.).
背景技术 Background technique
鲜地黄为玄参科植物地黄(Rehmannia glutinosa Libosch.)的新鲜块根,秋季采挖,除去芦头、须根及泥沙,鲜用,即为鲜地黄。历代名家对其均有论述和研究,认为其性甘、苦、寒,归心、肝、肾经,清热生津,凉血,止血,主用于热病伤阴,舌绛烦渴,发斑发疹,吐血,衄血,咽喉肿痛。现代药理及临床研究表明鲜地黄可用于炎性疾病的治疗,如中耳炎、咽喉炎、关节炎、肝炎、红斑狼疮、肾炎、糖尿病等。但是至今仍未有关于鲜地黄雌激素样活性方面的研究报道。Fresh Rehmannia glutinosa is the fresh root tuber of Rehmannia glutinosa Libosch., which is excavated in autumn, removed the reed heads, fibrous roots and sediment, and freshly used, which is Fresh Rehmannia glutinosa. Famous experts of all dynasties have discussed and studied it, thinking that it is sweet, bitter, and cold in nature, returns to the heart, liver, and kidney meridian, clears away heat and promotes body fluid, cools blood, and stops bleeding. Rash, vomiting blood, epistaxis, sore throat. Modern pharmacological and clinical studies have shown that fresh rehmannia can be used in the treatment of inflammatory diseases, such as otitis media, pharyngitis, arthritis, hepatitis, lupus erythematosus, nephritis, diabetes, etc. But there is still no research report on the estrogen-like activity of fresh rehmannia glutinosa.
发明内容 Contents of the invention
针对上述情况,为克服现有技术之缺陷,本发明之目的就是提供一种鲜地黄水提物在制备雌激素类药物中的应用,可有效解决制备由于体内雌性激素分泌不足而引起的相关疾病(如妇女更年期综合症等)的药物,从而有效解决由于体内雌性激素分泌不足而引起的相关疾病(如妇女更年期综合症等)的治疗用药问题。In view of the above situation, in order to overcome the defects of the prior art, the purpose of the present invention is to provide an application of fresh rehmannia glutinosa water extract in the preparation of estrogen drugs, which can effectively solve the related diseases caused by insufficient secretion of estrogen in the body. (such as women's climacteric syndrome, etc.), thereby effectively solving the problem of the treatment of related diseases (such as women's climacteric syndrome, etc.) caused by insufficient secretion of estrogen in the body.
本发明解决的技术方案是,鲜地黄水提物在制备雌激素药物中的应用,该鲜地黄水提物是,将鲜地黄每次用其10倍重量的水煎煮2次,每次2h,合并2次水煎液,减压浓缩干燥得到鲜地黄水提物,该鲜地黄水提物可有效用于制备治疗由于体内雌性激素分泌不足而引起的相关疾病的药物,实现鲜地黄水提物在制备治疗由于体内雌性激素分泌不足而引起的相关疾病(如妇女更年期综合症等)药物中的应用。The technical scheme solved by the present invention is the application of the fresh rehmannia water extract in the preparation of estrogen drugs. The fresh rehmannia root water extract is decocting fresh rehmannia rehmannia twice with water 10 times its weight each time for 2 hours , combined two decoctions, concentrated and dried under reduced pressure to obtain fresh rehmannia water extract, the fresh rehmannia water extract can be effectively used to prepare medicines for treating related diseases caused by insufficient secretion of estrogen in the body, and realize the fresh rehmannia water extract Application of the drug in the preparation of drugs for treating related diseases (such as women's climacteric syndrome, etc.) caused by insufficient secretion of estrogen in the body.
本发明水提物制备方法简单,稳定可靠,并经多次试验,均取得了相同或相近似的结果,方便,成本低,其水提物有效用于制备雌激素类药物,开辟了鲜地黄药用新用途,临床意义巨大。The preparation method of the water extract of the present invention is simple, stable and reliable, and after many tests, the same or similar results have been obtained, which is convenient and low in cost. New medicinal use, great clinical significance.
附图说明 Description of drawings
图1为本发明鲜地黄水提物对MCF-7细胞增殖的影响示意图。Fig. 1 is the effect of fresh rehmannia glutinosa water extract of the present invention on MCF-7 cell proliferation schematic diagram.
图2为本发明鲜地黄水提物对性未成熟小鼠子宫系数的影响示意图。Fig. 2 is the influence of fresh rehmannia glutinosa water extract of the present invention on the uterine coefficient of immature mice schematic diagram.
图3为本发明鲜地黄水提物对ERE调控的报告基因瞬时表达结果示意图。Fig. 3 is the transient expression result of the reporter gene regulated by fresh rehmannia glutinosa water extract of the present invention to ERE schematic diagram.
图4为本发明鲜地黄水提物对ERE调控的报告基因瞬时表达结果示意图。Fig. 4 is the transient expression result of the reporter gene regulated by fresh rehmannia glutinosa water extract of the present invention to ERE schematic diagram.
具体实施方式 Detailed ways
以下结合实施例和有关试验资料对本发明的具体情况作详细说明。Below in conjunction with embodiment and relevant test data the concrete situation of the present invention is described in detail.
本发明在具体实施中,所述的鲜地黄水提物在制备雌激素类药物中的应用,该鲜地黄水提物是由以下实施例给出:In the specific implementation of the present invention, the application of the described fresh rehmannia glutinosa water extract in the preparation of estrogen drugs, the fresh rehmannia glutinosa water extract is given by the following examples:
实施例1Example 1
本发明在具体实施中,所述的鲜地黄水提物是,将鲜地黄(Rehmannia glutinosaLibosch.)100g用其10倍重量的水1000g(即1000ml)煎煮2次,每次2h,合并两次水煎液,减压浓缩干燥得到鲜地黄水提物,得率为12.03%,该水提物可制备雌激素类药物,用于治疗由于体内雌性激素分泌不足而引起的疾病,如妇女更年期综合症药。In the specific implementation of the present invention, the fresh rehmannia water extract is that fresh rehmannia glutinosa (Rehmannia glutinosa Libosch.) 100g is decocted twice with 10 times the weight of water 1000g (i.e. 1000ml), each time for 2h, and combined twice The water decoction was concentrated and dried under reduced pressure to obtain the water extract of fresh rehmannia glutinosa with a yield of 12.03%. The water extract can be used to prepare estrogen drugs for the treatment of diseases caused by insufficient secretion of estrogen in the body, such as women's climacteric syndrome disease medicine.
实施例2Example 2
本发明在具体实施中,所述的鲜地黄水提物是,将鲜地黄(Rehmannia glutinosaLibosch.)200g用其10倍重量的水2000g(即2000ml)煎煮2次,每次2h,合并两次水煎液,减压浓缩干燥得到鲜地黄水提物,得率为15.84%,该水提物可制备雌激素类药物,用于治疗由于体内雌性激素分泌不足而引起的疾病,如妇女更年期综合症药。In the specific implementation of the present invention, the fresh rehmannia water extract is that fresh rehmannia (Rehmannia glutinosa Libosch.) 200g is decocted twice with 2000g (i.e. 2000ml) of water 10 times its weight, each time for 2h, and combined twice The water decoction was concentrated and dried under reduced pressure to obtain the water extract of fresh rehmannia glutinosa with a yield of 15.84%. The water extract can be used to prepare estrogen drugs for the treatment of diseases caused by insufficient secretion of estrogen in the body, such as women's climacteric syndrome disease medicine.
实施例3Example 3
本发明在具体实施中,所述的鲜地黄水提物是,将鲜地黄(Rehmannia glutinosaLibosch.)300g用其10倍重量的水3000g(即3000ml)煎煮2次,每次2h,合并两次水煎液,减压浓缩干燥得到鲜地黄水提物,得率为14.99%,该水提物可制备雌激素类药物,用于治疗由于体内雌性激素分泌不足而引起的疾病,如妇女更年期综合症药。In the specific implementation of the present invention, the fresh rehmannia water extract is that fresh rehmannia (Rehmannia glutinosa Libosch.) 300g is decocted twice with 3000g (i.e. 3000ml) of water 10 times its weight, each time for 2h, and merged twice The water decoction was concentrated and dried under reduced pressure to obtain the water extract of fresh rehmannia glutinosa with a yield of 14.99%. The water extract can be used to prepare estrogen drugs for the treatment of diseases caused by insufficient secretion of estrogen in the body, such as women's climacteric syndrome disease medicine.
根据上述方法按鲜地黄和水的比例可以通过工业化生产制得任意量的鲜地黄水提物,并经反复实验,均取得了相同和相近似的结果,方法稳定可靠,所得鲜地黄水提物用于制备雌激素类药物,有效解决由于体内雌性激素分泌不足而引起的疾病(如妇女更年期综合症等)的用药治疗问题,并经试验得到了充分证明,有关试验资料如下:According to the above method, any amount of fresh rehmannia water extract can be produced by industrial production according to the ratio of fresh rehmannia glutinosa and water, and through repeated experiments, the same and similar results have been obtained. The method is stable and reliable, and the obtained fresh rehmannia glutinosa water extract It is used for the preparation of estrogen drugs, which can effectively solve the problem of drug treatment of diseases (such as women's climacteric syndrome) caused by insufficient secretion of estrogen in the body, and has been fully proved by tests. The relevant test data are as follows:
采用细胞增殖实验、动物实验及报告基因技术对其进行了充分证明,其有关试验资料如下:It has been fully proved by cell proliferation experiments, animal experiments and reporter gene technology, and the relevant test data are as follows:
首先通过MCF-7细胞增殖实验(E-SCREEN),发现鲜地黄水提物能够促进MCF-7细胞的增殖,说明其在体外具有雌激素样作用。First, through the MCF-7 cell proliferation experiment (E-SCREEN), it was found that fresh rehmannia glutinosa water extract can promote the proliferation of MCF-7 cells, indicating that it has estrogen-like effects in vitro.
其次通过小鼠子宫增重实验,证明鲜地黄水提物能够显著增加性未成熟雌性小鼠的子宫系数,说明其在体内具有雌激素样作用。Secondly, through the mouse uterine weight gain experiment, it is proved that the water extract of fresh rehmannia glutinosa can significantly increase the uterine coefficient of immature female mice, indicating that it has estrogen-like effects in vivo.
最后通过ERE调控的报告基因瞬时表达检测,进一步验证鲜地黄水提物是通过与雌激素受体ERβ的结合而发挥雌激素样作用。Finally, through the transient expression detection of the reporter gene regulated by ERE, it was further verified that the water extract of fresh rehmannia glutinosa exerted estrogen-like effects by binding to the estrogen receptor ERβ.
发明人已通过实验证明了本发明药物在制备雌激素类药物中的新用途。其主要实施方案如下:The inventor has proved the new application of the drug of the present invention in the preparation of estrogen drugs through experiments. Its main implementation scheme is as follows:
一、实验材料与方法1. Experimental materials and methods
1.实验药物1. Experimental drug
玄参科植物地黄(Rehmannia glutinosa Libosch.)的新鲜块根。秋季采挖,除去芦头、须根及泥沙,即为鲜地黄。The fresh tuber root of Rehmannia glutinosa Libosch. Excavated in autumn, remove reed heads, fibrous roots and sediment, that is fresh rehmannia glutinosa.
鲜地黄以10倍重量的水煎煮2次,每次2h,水煎液减压干燥浓缩干燥得到鲜地黄水提物。Fresh Rehmannia glutinosa was decocted twice with 10 times the weight of water, each time for 2 hours, and the decoction was dried under reduced pressure, concentrated and dried to obtain fresh rehmannia glutinosa water extract.
2.实验动物与细胞株及质粒2. Experimental animals, cell lines and plasmids
昆明种小鼠,雌性,出生21天(刚断乳),体重9~12g,购于河南省实验动物中心。人乳腺癌细胞(MCF-7)由中国军事医学科学院生物工程研究所提供。HEK293细胞株购于中国典型培养物保藏中心。β-半乳糖苷酶(β-galactosidase,β-gal)对照质粒pβgal-Control、重组报告基因pERE-TAL-luc由军事医学科学院生物工程研究所叶棋浓博士惠赠。重组人ERα(humanERα,hERα)表达载体pCXN2-hERα和重组人ERβ(humanERβ,hERβ)表达载体pCXN2-hERβ由东京大学医学系Satoshi Inoue博士惠赠。Kunming mice, female, 21 days old (just weaned), weighing 9-12 g, were purchased from Experimental Animal Center of Henan Province. Human breast cancer cells (MCF-7) were provided by the Institute of Bioengineering, Chinese Academy of Military Medical Sciences. HEK293 cell lines were purchased from China Center for Type Culture Collection. The β-galactosidase (β-galactosidase, β-gal) control plasmid pβgal-Control and the recombinant reporter gene pERE-TAL-luc were donated by Dr. Ye Qinong, Institute of Bioengineering, Academy of Military Medical Sciences. The recombinant human ERα (humanERα, hERα) expression vector pCXN2-hERα and recombinant human ERβ (humanERβ, hERβ) expression vector pCXN2-hERβ were donated by Dr. Satoshi Inoue, Faculty of Medicine, University of Tokyo.
3.主要试剂3. Main reagents
RPMI1640培养基、小牛血清(Newborn Calf Serum,NCS)和脂质体LipofectamineTM2000Reagent购自Gibco Invitrogen公司;胎牛血清、无酚红RPMIl640培养基、17β-雌二醇(17β-estrogen,E2)、氨苄青霉素(Amp)、Tris碱和活性炭(Charcoal)均购自Sigma公司;葡聚糖T-70(Dextran-70)购自上海化学试剂公司;己烯雌酚片(合肥久联制药);邻-硝基苯-β-D-半乳吡喃糖苷(O-Nitrophenyl-β-D-galactopy ranoside,ONPG)、EDTA、MTT及DMSO为Amresco公司产品;稳定荧光素酶检测系统试剂盒Luciferase AssaySysterm)、闪亮裂解缓冲液(Glo lysis Buffer)购自Promega公司;其余试剂均为国产分析纯。RPMI1640 medium, calf serum (Newborn Calf Serum, NCS) and liposome LipofectamineTM2000Reagent were purchased from Gibco Invitrogen; fetal bovine serum, phenol red-free RPMI1640 medium, 17β-estradiol (17β-estrogen, E 2 ), Ampicillin (Amp), Tris base and activated carbon (Charcoal) were purchased from Sigma; dextran T-70 (Dextran-70) was purchased from Shanghai Chemical Reagent Company; diethylstilbestrol tablets (Hefei Jiulian Pharmaceutical); Benzene-β-D-galactopyranoside (O-Nitrophenyl-β-D-galactopy ranoside, ONPG), EDTA, MTT and DMSO are products of Amresco; Stable Luciferase Assay System Kit Luciferase Assay System), Shiny lysis buffer (Glo lysis Buffer) were purchased from Promega Company; the rest of the reagents were domestic analytical grade.
4.所用主要仪器4. Main instruments used
普通手术器械;二氧化碳培养箱(REVCO);倒置显微镜(NIKON ECLIPSE TS100);KDC-160HR高速低温冷冻离心机(科大创新般份有限公司);酶标仪(BIO-RAD 680);纯水仪(Sartorius 611VF);90-3磁力搅拌器(上海振捷实验设备有限公司);ZRD-7080全自动新型鼓风干燥箱(上海智城分析仪器制造有限公司);微量加样器(Nichipet EX PLUS);AB204-N电子读数分析天平(梅特勒-托利多仪器(上海)有限公司产品);10cm培养皿、96孔培养板、冻存管均为Corning公司生产;超净工作台(江苏苏净集团);UV-7504PC型紫外-可见分光光度计(福州健洋科技仪器有限公司);VeritasTM微板光度计(TurnerBioSystems公司);SK6200H型超声波清洗器(上海科导超声仪器有限公司);SHP-150型生化培养箱(上海精宏实验设备有限公司)。General surgical instruments; carbon dioxide incubator (REVCO); inverted microscope (NIKON ECLIPSE TS100); KDC-160HR high-speed low-temperature refrigerated centrifuge (KUST Innovations Co., Ltd.); microplate reader (BIO-RAD 680); pure water instrument ( Sartorius 611VF); 90-3 magnetic stirrer (Shanghai Zhenjie Experimental Equipment Co., Ltd.); ZRD-7080 fully automatic new blast drying oven (Shanghai Zhicheng Analytical Instrument Manufacturing Co., Ltd.); micro sampler (Nichipet EX PLUS) ; AB204-N electronic reading analysis balance (Mettler-Toledo Instrument (Shanghai) Co., Ltd. product); 10cm culture dish, 96-well culture plate, cryopreservation tube are all produced by Corning Company; Group); UV-7504PC UV-Vis Spectrophotometer (Fuzhou Jianyang Technology Instrument Co., Ltd.); VeritasTM Microplate Photometer (TurnerBioSystems); SK6200H Ultrasonic Cleaner (Shanghai Kedao Ultrasonic Instrument Co., Ltd.); SHP- 150-type biochemical incubator (Shanghai Jinghong Experimental Equipment Co., Ltd.).
5.实验方法5. Experimental method
5.1MCF-7细胞增殖实验5.1 MCF-7 cell proliferation assay
MCF-7细胞经无酚红含10%去激素血清的RPMI1640培养基培养2周后,选取对数生长期细胞,PBS洗两次,用0.25%胰蛋白酶消化后,加入无酚红含2%去激素血清的RPMI1640培养基吹打均匀,以1×104个/ml的浓度接种于96孔板内,每孔培养总体积为200μl。培养24h待细胞贴壁后,换为含药培养液继续培养。37℃、5%CO2培养72h后,每孔加入MTT溶液(5mg/ml)20μl,37℃继续培养4h,小心吸净培养液,每孔加入150μlDMSO,震荡5~10min,使结晶物完全溶解。以DMSO调零,用酶标仪在490nm下测定各孔吸光度值(A),计算平均A值和增殖率(Proliferation Rate,RP)。实验平行重复三次。After MCF-7 cells were cultured in RPMI1640 medium containing 10% hormone-free serum without phenol red for 2 weeks, the cells in the logarithmic growth phase were selected, washed twice with PBS, digested with 0.25% trypsin, and added with 2% serum without phenol red The RPMI1640 medium with hormone-free serum was pipetted evenly, and inoculated in a 96-well plate at a concentration of 1×10 4 cells/ml, and the total culture volume of each well was 200 μl. After culturing for 24 hours, after the cells adhered to the wall, they were replaced with drug-containing medium to continue culturing. After culturing at 37°C and 5% CO2 for 72 hours, add 20 μl of MTT solution (5 mg/ml) to each well, continue to cultivate at 37°C for 4 hours, carefully aspirate the culture solution, add 150 μl DMSO to each well, and shake for 5-10 minutes to completely dissolve the crystals . Adjust to zero with DMSO, measure the absorbance value (A) of each well at 490 nm with a microplate reader, and calculate the average A value and the proliferation rate (Proliferation Rate, RP). The experiment was repeated three times in parallel.
RP=实验组A值/空白组A值)-1×100%RP=experimental group A value/blank group A value) -1 × 100%
5.2小鼠子宫增重实验5.2 Mouse uterus weight gain experiment
将小鼠按体重均衡和随机的原则分组。给药持续7天。空白对照组每日蒸馏水0.2ml/10g灌胃;阳性对照组每日己烯雌酚悬浊液(0.35mg/kg/d)灌胃;鲜地黄水提物按临床用药的20倍量×提取率计算,配成相应浓度的混悬液,每日按0.2ml/10g灌胃。最后一次给药24h后,脱颈处死小鼠,立即摘取子宫称重,计算子宫系数(子宫湿重×(体重)-1×100%)。实验平行重复三次。结果与空白组相比,计算P值考察有无统计学意义。The mice were divided into groups according to the principle of weight balance and randomization. Dosing continued for 7 days. The blank control group was intragastrically administered with 0.2ml/10g of distilled water every day; the positive control group was intragastrically administered with diethylstilbestrol suspension (0.35mg/kg/d) every day; Make a suspension of corresponding concentration, and give it to the stomach at 0.2ml/10g every day. 24 hours after the last administration, the mice were killed by cervical dislocation, and the uterus was immediately removed and weighed, and the uterine coefficient was calculated (wet weight of uterus × (body weight) - 1 × 100%). The experiment was repeated three times in parallel. Results Compared with the blank group, calculate the P value to see if there is any statistical significance.
5.3ERE调控的报告基因瞬时表达检测5.3 Detection of transient expression of reporter genes regulated by ERE
5.3.1细胞接种5.3.1 Cell Seeding
于转染前72h将处于对数生长期的HEK293细胞接种于24孔板,密度为16.0×104个/0.5ml/孔,且培养液为含10%去雌激素血清的无酚红RPMI1640培养液,分别设置空白对照孔、雌二醇孔及待测药物孔。72 hours before transfection, HEK293 cells in the logarithmic growth phase were inoculated on a 24-well plate at a density of 16.0× 104 /0.5ml/well, and the culture medium was phenol red-free RPMI1640 culture containing 10% estrogen-depleted serum solution, respectively set blank control wells, estradiol wells and drug wells to be tested.
5.3.2质粒的转染5.3.2 Transfection of plasmids
(1)72h后开始转染,小心吸出原培养基,加入400μl含10%去雌激素血清的无酚红RPMI1640培养基。(1) Transfection was started after 72 hours, the original medium was carefully sucked out, and 400 μl of phenol red-free RPMI1640 medium containing 10% estrogen-depleted serum was added.
(2)取3只EP管,ERα管中加500μl无酚红RPMI1640培养基、8μlpCXN2-hERα质粒、8μlpERE-TAL-luc质粒、8μlpβgal-Control质粒;ERβ管中加500μl无酚红RPMI1640培养基、8μlpCXN2-hERβ质粒、8μlpERE-TAL-Iuc质粒、8μl βgal-Control质粒;脂质体管中加入1000μl无酚红RPMI1640培养基和24μl脂质体。(2) Take 3 EP tubes, add 500 μl phenol red-free RPMI1640 medium, 8 μlpCXN2-hERα plasmid, 8μlpERE-TAL-luc plasmid, 8μlpβgal-Control plasmid to ERα tube; add 500μl phenol red-free RPMI1640 medium, 8 μl of CXN2-hERβ plasmid, 8 μl of ERE-TAL-Iuc plasmid, 8 μl of βgal-Control plasmid; 1000 μl of phenol red-free RPMI1640 medium and 24 μl of liposomes were added to the liposome tube.
(3)倒转混匀脂质体管,室温放置5min,取500μl分别加入ERα和ERβ管,室温放置20min;(3) Invert and mix the liposome tube, place at room temperature for 5 minutes, take 500 μl into ERα and ERβ tubes respectively, and place at room temperature for 20 minutes;
(4)倒转混匀ERα和ERβ管,取80μlERα管中脂质体/DNA复合物分别加入24孔板ERα实验孔,取80μlERβ管中脂质体/DNA复合物分别加入24孔板ERβ实验孔。前后摇匀,放入培养箱。(4) Invert and mix the ERα and ERβ tubes, add 80 μl of the liposome/DNA complexes in the ERα tubes to the ERα experimental wells of the 24-well plate, and add 80 μl of the liposome/DNA complexes in the ERβ tubes to the ERβ experimental wells of the 24-well plate respectively . Shake back and forth and place in the incubator.
(5)6h后加入对照药物和检测药物。(5) Add control drug and test drug after 6 hours.
5.3.3ERE调控的报告基因瞬时表达检测加药后24h的细胞,吸去培养液,用1mlPBS洗一次,并移去PBS。按照稳定荧光素酶检测系统试剂盒(Steady-Luciferase Assay Systerm)及闪亮裂解缓冲液(Glolysis Buffer)改良操作步骤操作,收集细胞裂解上清液,加入荧光素酶反应底物(荧光素),置于暗处,用VeritasTM微板光度计检测荧光强度。5.3.3 Detection of transient expression of reporter gene regulated by ERE For the cells 24 hours after drug addition, the culture medium was aspirated, washed once with 1ml PBS, and the PBS was removed. according to Stable luciferase detection system kit (Steady- Luciferase Assay System) and shiny lysis buffer (Glolysis Buffer) to improve the operation steps, collect the cell lysate supernatant, add the luciferase reaction substrate (luciferin), put it in the dark, and detect it with a VeritasTM microplate photometer The fluorescence intensity.
5.3.4β-gal活性检测5.3.4 β-gal activity detection
为了考察转染效率,对内参照β-gal活性进行了检测。In order to examine the transfection efficiency, the internal reference β-gal activity was detected.
(1)54μlβ-巯基乙醇加入40ml Z-buffer中,混匀,取EP管,每管加1800μl;(1) Add 54μl β-mercaptoethanol to 40ml Z-buffer, mix well, take EP tubes, add 1800μl to each tube;
(2)每管加20μl裂解上清液;(2) Add 20 μl lysed supernatant to each tube;
(3)每管加400μl ONPG,倒转混匀;(3) Add 400μl ONPG to each tube, invert and mix;
(4)放置37℃温箱,至显黄色;(4) Place in a 37°C incubator until it turns yellow;
(5)加Na2CO31ml终止反应;(5) Add Na 2 CO 3 1ml to terminate the reaction;
(6)测OD420值;(6) Measure OD 420 value;
二、统计处理2. Statistical processing
实验数据以表示,SPSS13.0进行单因素方差分析(One-Way ANOVA)统计处理。Experimental data with Said, SPSS13.0 for one-way analysis of variance (One-Way ANOVA) statistical processing.
三、实验结果3. Experimental results
1.鲜地黄水提物对MCF-7细胞增殖影响的实验结果1. Experimental results of the effect of fresh rehmannia glutinosa water extract on the proliferation of MCF-7 cells
结果显示,鲜地黄水提物的剂量在0.01~1mg/ml时与空白组相比对MCF-7细胞均有显著促增殖作用(P<0.01)。说明鲜地黄水提物在体外具有雌激素样作用。见表1,图1。The results showed that compared with the blank group, the fresh rehmannia glutinosa water extract had a significant proliferation-promoting effect on MCF-7 cells (P<0.01). It shows that the water extract of fresh rehmannia glutinosa has estrogen-like effects in vitro. See Table 1, Figure 1.
表1 鲜地黄水提物对MCF-7细胞增殖的影响 Table 1 The effect of fresh rehmannia glutinosa water extract on the proliferation of MCF-7 cells
注:与空白对照组比较,☆表示P<0.05,★表示P<0.01;与阳性组比较,△表示P<0.05,▲表示P<0.01。Note: Compared with the blank control group, ☆ means P<0.05, ★ means P<0.01; compared with the positive group, △ means P<0.05, ▲ means P<0.01.
2.鲜地黄水提物对小鼠子宫系数影响的实验结果2. Experimental results of the effect of fresh rehmannia glutinosa water extract on the uterine coefficient of mice
结果显示,鲜地黄水提物组与空白对照组相比能显著诱导性未成熟小鼠子宫系数的增加(P<0.01),说明鲜地黄水提物在体内具有雌激素样作用。见表2,图2。The results showed that the fresh rehmannia water extract group could significantly induce the increase of the uterine coefficient of immature mice compared with the blank control group (P<0.01), indicating that the fresh rehmannia water extract had estrogen-like effects in vivo. See Table 2, Figure 2.
表2鲜地黄水提物对性未成熟小鼠子宫系数的影响 Table 2 The effect of fresh rehmannia glutinosa water extract on the uterine coefficient of immature mice
注:与空白对照组比较,☆表示P<0.05,★表示P<0.01;与阳性对照组比较,△表示P<0.05,▲表示P<0.01。Note: Compared with the blank control group, ☆ means P<0.05, ★ means P<0.01; compared with the positive control group, △ means P<0.05, ▲ means P<0.01.
3.ERE调控的报告基因瞬时表达检测评价鲜地黄水提物是否通过受体途径发挥的雌激素样作用3. ERE-regulated reporter gene transient expression detection to evaluate whether fresh rehmannia glutinosa water extract exerts estrogen-like effects through receptor pathway
利用报告基因技术检测鲜地黄水提物与雌激素受体(Estrogen Receptors,ERs)相互作用的影响,阳性对照组即17-雌二醇(E2)加入的终浓度为10-8mol/L,鲜地黄水提物加药浓度分别为0.001mg/ml、0.01mg/ml、0.1mg/ml、1mg/ml。结果显示,不论是由ERα或ERβ介导,E2标准化后的荧光素酶活性都显著高于空白孔(P<0.01)。由ERα介导时,鲜地黄水提物0.001mg/ml~1mg/ml四个剂量组标准化后的荧光素酶活性与空白孔相比都无统计学意义(P>0.05),见表3,图3。由ERβ介导时,鲜地黄水提物0.001mg/ml、0.01mg/ml、0.1mg/ml、1mg/ml组标准化后的荧光素酶活性都显著高于空白孔(P<0.01),且具有剂量依赖性。见表4、图4。The effect of the interaction between fresh rehmannia glutinosa water extract and estrogen receptors (Estrogen Receptors, ERs) was detected by reporter gene technology, and the final concentration of 17-estradiol (E 2 ) in the positive control group was 10 -8 mol/L , fresh rehmannia glutinosa water extract dosing concentrations were 0.001mg/ml, 0.01mg/ml, 0.1mg/ml, 1mg/ml. The results showed that, whether mediated by ERα or ERβ, the normalized luciferase activity of E2 was significantly higher than that of blank wells (P<0.01). When mediated by ERα, the normalized luciferase activity of four dosage groups of fresh rehmannia glutinosa water extract 0.001mg/ml~1mg/ml was not statistically significant compared with the blank well (P>0.05), see Table 3, image 3. When mediated by ERβ, the luciferase activity after normalization of fresh rehmannia glutinosa water extract 0.001mg/ml, 0.01mg/ml, 0.1mg/ml, 1mg/ml group was significantly higher than that of the blank well (P<0.01), and It is dose-dependent. See Table 4 and Figure 4.
表3鲜地黄水提物对ERE调控的报告基因瞬时表达检测结果 Table 3 Detection results of transient expression of reporter gene regulated by fresh rehmannia glutinosa water extract on ERE
注:与空白对照组比较,☆表示P<0.05,★表示P<0.01;与阳性组比较,△表示P<0.05,▲表示P<0.01。Note: Compared with the blank control group, ☆ means P<0.05, ★ means P<0.01; compared with the positive group, △ means P<0.05, ▲ means P<0.01.
表4鲜地黄水提物对ERE调控的报告基因瞬时表达检测结果 Table 4 Detection results of transient expression of reporter gene regulated by fresh rehmannia glutinosa water extract on ERE
注:与空白对照组比较,☆表示P<0.05,★表示P<0.01;与阳性组比较,△表示P<0.05,▲表示P<0.01。Note: Compared with the blank control group, ☆ means P<0.05, ★ means P<0.01; compared with the positive group, △ means P<0.05, ▲ means P<0.01.
MCF-7细胞增殖实验结果显示,鲜地黄水提物的浓度0.01mg/ml~1mg/ml时对MCF-7细胞具有显著的增殖作用,且在0.1mg/ml时作用最强。The results of MCF-7 cell proliferation experiment showed that fresh rehmannia glutinosa water extract had a significant proliferation effect on MCF-7 cells when the concentration was 0.01mg/ml-1mg/ml, and the effect was the strongest at 0.1mg/ml.
小鼠子宫增重实验结果显示,鲜地黄水提物可显著增加性未成熟小鼠子宫系数,说明鲜地黄水提物在体内、体外均具有雌激素样活性。The results of mouse uterine weight gain experiments showed that the water extract of fresh rehmannia glutinosa can significantly increase the uterine coefficient of immature mice, indicating that the water extract of fresh rehmannia glutinosa has estrogen-like activity both in vivo and in vitro.
ERE调控的报告基因瞬时表达检测结果显示,鲜地黄水提物的雌激素样作用主要是通过ERβ介导,浓度在0.001mg/ml、0.01mg/ml、0.1mg/ml、1mg/ml均能激活ERβ介导的基因转录,且具有剂量依赖性;但对ERα介导的基因转录,鲜地黄水提物在0.001mg/ml、0.01mg/ml、0.1mg/ml、1mg/ml时与空白孔相比均无影响。The test results of the transient expression of the reporter gene regulated by ERE showed that the estrogen-like effect of fresh rehmannia glutinosa water extract was mainly mediated by ERβ, and the concentration of 0.001mg/ml, 0.01mg/ml, 0.1mg/ml, 1mg/ml could Activation of gene transcription mediated by ERβ was dose-dependent; but for gene transcription mediated by ERα, fresh rehmannia glutinosa water extract was comparable to blank at 0.001mg/ml, 0.01mg/ml, 0.1mg/ml, 1mg/ml Holes have no effect.
综上所述,动物及细胞实验结果显示,鲜地黄水提物具有一定的雌激素样作用,其主要是通过ERβ介导的基因转录而发挥雌激素样作用。To sum up, the results of animal and cell experiments show that fresh rehmannia glutinosa water extract has certain estrogen-like effects, which are mainly through ERβ-mediated gene transcription to exert estrogen-like effects.
四、结论4. Conclusion
MCF-7细胞是雌激素受体阳性的人乳腺癌细胞株,能特异地受雌激素或雌激素样活性物质调节而增殖,是最常用的检测雌激素样活性的细胞株。MCF-7细胞雌激素样增殖试验非常灵敏,可以区分雌激素激动剂和拮抗剂,因而被广泛应用于体外大量、快速筛选和评价环境雌激素和植物雌激素。在鲜地黄水提物对MCF-7细胞增殖影响的实验中,鲜地黄水提物在0.01mg/ml~1mg/ml时对MCF-7细胞均具有显著的促增殖作用,说明了鲜地黄水提物在体外具有雌激素样活性。MCF-7 cells are estrogen receptor-positive human breast cancer cell lines, which can be specifically regulated by estrogen or estrogen-like active substances to proliferate, and are the most commonly used cell lines for detecting estrogen-like activity. The MCF-7 cell estrogen-like proliferation assay is very sensitive and can distinguish estrogen agonists and antagonists, so it is widely used in large quantities and rapid screening and evaluation of environmental estrogens and phytoestrogens in vitro. In the experiment of the effect of fresh rehmannia water extract on the proliferation of MCF-7 cells, the fresh rehmannia water extract has a significant effect on the proliferation of MCF-7 cells at 0.01mg/ml~1mg/ml, which shows that fresh rehmannia water The extract has estrogen-like activity in vitro.
子宫增重实验是最早建立的检测雌激素活性的经典方法,在评价雌激素活性时,它考虑了物质的吸收、代谢、与血浆蛋白结合以及药代动力学等多方面因素,直接反映受试药物经体内代谢后的总体生物学效应。因此,本实验采用性未成熟雌性小鼠子宫湿重与体重之比(子宫系数)作为评价雌激素样活性的指标。结果显示,鲜地黄水提物可显著增加性未成熟小鼠子宫系数,证明鲜地黄水提物在体内具有雌激素样作用。Uterine weight gain test is the earliest established classic method to detect estrogen activity. When evaluating estrogen activity, it takes into account the absorption, metabolism, binding to plasma protein and pharmacokinetics of substances and other factors, directly reflecting the test results. The overall biological effect of a drug after it has been metabolized in the body. Therefore, the ratio of uterine wet weight to body weight (uterine coefficient) of sexually immature female mice was used as an index for evaluating estrogen-like activity in this experiment. The results showed that the water extract of fresh rehmannia can significantly increase the uterine coefficient of immature mice, which proves that the water extract of fresh rehmannia has estrogen-like effects in vivo.
上述试验反复进行多次,均取得了相同或相近的结果,提示,鲜地黄水提物在体内、体外均具有一定的雌激素样作用。The above experiments were repeated many times, and all obtained the same or similar results, suggesting that the water extract of fresh rehmannia glutinosa has certain estrogen-like effects both in vivo and in vitro.
报告基因(reporter gene)是其表达产物非常容易检测、与内源性背景蛋白较易区别的一类基因。通过基因工程手段,将应答元件和报告基因相连,通过检测报告基因表达活性,可得知信号转导途径的活性及其对细胞内基因表达的调控和影响。报告基因技术灵敏度高、选择性强且操作简单。在鲜地黄水提物对报告基因载体pERE-TAL-luc瞬时表达的诱导作用实验中,用以ERE调控报告基因的瞬时转染,将分别载有ERα、ERβ及以ERE序列作为调控元件构建的重组报告基因载体质粒瞬时共转染靶细胞(HEK 293)为药物筛选模型,加入不同浓度的受试药物后,通过观察报告基因的表达情况,即荧光强度的高低可以检测到受试物是否可以与雌激素受体(ER)结合,从而了解鲜地黄水提物雌激素样作用的强弱以及其与ERα或ERβ亲和力的大小。从实验结果中可见,鲜地黄水提物可通过雌激素受体(ER)诱导luc荧光的表达,且鲜地黄水提物激活基因转录主要是通过ERβ介导的,这与植物雌激素对ERβ亲和力更高的文献报道一致。Reporter gene is a kind of gene whose expression product is very easy to detect and easy to distinguish from endogenous background protein. By means of genetic engineering, the response element is connected to the reporter gene, and by detecting the expression activity of the reporter gene, the activity of the signal transduction pathway and its regulation and influence on intracellular gene expression can be known. Reporter gene technology has high sensitivity, strong selectivity and simple operation. In the induction experiment of fresh rehmannia glutinosa water extract on the transient expression of reporter gene vector pERE-TAL-luc, ERE was used to regulate the transient transfection of the reporter gene, and the vectors carrying ERα, ERβ and ERE sequences as regulatory elements were constructed respectively. Recombinant reporter gene carrier plasmid transiently co-transfects target cells (HEK 293) as a drug screening model. After adding different concentrations of test drugs, by observing the expression of the reporter gene, that is, the level of fluorescence intensity can detect whether the test substance can Combine with estrogen receptor (ER), so as to understand the strength of estrogen-like effect of fresh rehmannia glutinosa water extract and its affinity with ERα or ERβ. It can be seen from the experimental results that the water extract of fresh rehmannia glutinosa can induce the expression of luc fluorescence through the estrogen receptor (ER), and the activation of gene transcription by the water extract of fresh rehmannia glutinosa is mainly mediated by ERβ, which is similar to the effect of phytoestrogens on ERβ The literature reports with higher affinity are consistent.
有机体是一个复杂的体系,体内体外结果存在一定偏差。本实验应用体外细胞实验、体内整体动物实验及报告基因技术相结合共同来验证受试物的雌激素样活性,保证了结果的准确性。Organisms are complex systems, and there are certain deviations in in vivo and in vitro results. In this experiment, the combination of in vitro cell experiment, in vivo whole animal experiment and reporter gene technology is used to verify the estrogen-like activity of the test substance, which ensures the accuracy of the results.
由上述资料充分证明鲜地黄水提物能够促进MCF-7细胞的增殖和增加性未成熟小鼠子宫的湿重,进一步的ERE调控的报告基因瞬时表达检测技术提示鲜地黄水提物主要是通过ERβ介导而发挥雌激素样作用。也就是说,鲜地黄水提物具有雌激素样作用,可有效用于制备治疗由于体内雌性激素分泌不足而引起的相关疾病的药物,是中药鲜地黄在用途上的创新。The above data fully prove that the fresh rehmannia water extract can promote the proliferation of MCF-7 cells and increase the wet weight of the uterus of immature mice. Further ERE-regulated reporter gene transient expression detection technology suggests that the fresh rehmannia water extract is mainly through ERβ-mediated estrogen-like effects. That is to say, the water extract of fresh rehmannia glutinosa has estrogen-like effects, and can be effectively used to prepare medicines for treating related diseases caused by insufficient secretion of estrogen in the body, which is an innovation in the use of the traditional Chinese medicine fresh rehmannia glutinosa.
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210066495.9A CN102579673B (en) | 2012-03-15 | 2012-03-15 | Application of fresh rehmannia root aqueous extract in preparation of estrogen medicines |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210066495.9A CN102579673B (en) | 2012-03-15 | 2012-03-15 | Application of fresh rehmannia root aqueous extract in preparation of estrogen medicines |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102579673A CN102579673A (en) | 2012-07-18 |
| CN102579673B true CN102579673B (en) | 2014-04-02 |
Family
ID=46469275
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201210066495.9A Active CN102579673B (en) | 2012-03-15 | 2012-03-15 | Application of fresh rehmannia root aqueous extract in preparation of estrogen medicines |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102579673B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103055021A (en) * | 2013-01-10 | 2013-04-24 | 济南康众医药科技开发有限公司 | Freeze-dried fresh rehmannia for treating systemic lupus erythematosus |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2004155779A (en) * | 2002-10-16 | 2004-06-03 | Taisho Pharmaceut Co Ltd | Oral composition for prevention and treatment of menopause |
| CN1240414C (en) * | 2003-09-01 | 2006-02-08 | 江苏省中国科学院植物研究所 | Prepared Chinese medicine for improving function of female ovary as well as preparation method and application in pharmacy |
| US7482029B2 (en) * | 2005-04-01 | 2009-01-27 | Bionovo, Inc. | Composition for treatment of menopause |
| CN101269170B (en) * | 2008-03-05 | 2010-09-08 | 上海中医药大学 | A kind of medicine for treating climacteric syndrome and preparation method thereof |
| CN101966254A (en) * | 2010-10-08 | 2011-02-09 | 河南中医学院 | Application of raw rehmannia aqueous extract in preparing medicines for treating woman climacteric syndrome caused by hyposecretion of in-vivo female hormones |
-
2012
- 2012-03-15 CN CN201210066495.9A patent/CN102579673B/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CN102579673A (en) | 2012-07-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Fan et al. | Anti-inflammatory activity of baicalein in LPS-stimulated RAW264. 7 macrophages via estrogen receptor and NF-κB-dependent pathways | |
| Yu et al. | Protective effect of berberine against myocardial ischemia reperfusion injury: role of Notch1/Hes1-PTEN/Akt signaling | |
| Ho et al. | Resveratrol inhibits human leiomyoma cell proliferation via crosstalk between integrin αvβ3 and IGF-1R | |
| Ding et al. | Toxicity of cooking oil fume derived particulate matter: Vitamin D3 protects tubule formation activation in human umbilical vein endothelial cells | |
| Lu et al. | Saponins from Paris forrestii (Takht.) H. Li display potent activity against acute myeloid leukemia by suppressing the RNF6/AKT/mTOR signaling pathway | |
| CN101797265A (en) | Application of belamcanda chinensis total isoflavone or isoflavone compounds in preparing medicaments and food for preventing and treating women's disease | |
| CN102579673B (en) | Application of fresh rehmannia root aqueous extract in preparation of estrogen medicines | |
| Zhou et al. | Sipi soup inhibits cancer-associated fibroblast activation and the inflammatory process by downregulating long non-coding RNA HIPK1-AS | |
| CN102247471B (en) | Application of rehmannia root water extract to preparing estrogen medicament | |
| CN102805760A (en) | Application of twotooth achyranthes aqueous extract to preparation of estrogen medicines | |
| Yu et al. | Quyu Shengxin capsule (QSC) inhibits Ang-II-induced abnormal proliferation of VSMCs by down-regulating TGF-β, VEGF, mTOR and JAK-STAT pathways | |
| CN102526500A (en) | Application of dendrobium water extract to preparation of estrogen medicines | |
| Anandpara et al. | Investigation of therapeutics benefits of Dioscorea bulbifera in breast cancer | |
| CN102028728B (en) | Application of extract of Chinese angelica and szechuan lovage rhizome composition in preparation of medicament for promoting ovary granular cell proliferation | |
| CN107137457A (en) | Application of the flower bud of lily magnolia water extract as sole active agent in estrogenic is prepared | |
| CN105168301B (en) | Application of Tinglizi Aqueous Extract in Preparation of Estrogen Drugs | |
| CN104814973B (en) | Application of Cappariloside A in the preparation of medicaments for the treatment of influenza and influenza virus-mediated inflammatory diseases | |
| CN101703677B (en) | Application of composite of sweet wormwood herb and turtle shell in preparing antitumor medicine | |
| CN102805778B (en) | Application of Chinese wolfberry root-bark aqueous extract to preparation of estrogen medicines | |
| CN108310363B (en) | Application of CRM197 in preparation of medicine for treating polycystic ovarian syndrome | |
| Zheng et al. | Effects of royal jelly and its extracts on endometrial receptivity and MCF-7 cell growth in rats with thin endometrium | |
| CN101167816B (en) | preparation method of total glycosides of ranunculus and application thereof | |
| Almalki | The Effects of Wild Yam Root (Dioscorea villosa) Extract in Human Triple Negative MDA-MB-231 Breast Cancer Cells | |
| CN108727459B (en) | Tripterine aptamer conjugate and preparation method and application thereof | |
| CN104288239A (en) | Application of semen plantaginis water extract in preparation of estrogen drugs |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant |